US 12,283,374 B2
Noninvasive multi-parameter patient monitor
Ammar Al-Ali, San Juan Capistrano, CA (US); and Joe E. Kiani, Laguna Niguel, CA (US)
Assigned to Willow Laboratories, Inc., Irvine, CA (US)
Filed by Willow Laboratories, Inc., Irvine, CA (US)
Filed on Nov. 23, 2020, as Appl. No. 17/101,625.
Application 17/101,625 is a continuation of application No. 16/366,119, filed on Mar. 27, 2019, granted, now 10,856,788.
Application 16/366,119 is a continuation of application No. 15/138,008, filed on Apr. 25, 2016, granted, now 10,251,585, issued on Apr. 9, 2019.
Application 15/138,008 is a continuation of application No. 14/557,761, filed on Dec. 2, 2014, granted, now 9,351,675, issued on May 31, 2016.
Application 14/557,761 is a continuation of application No. 14/076,556, filed on Nov. 11, 2013, granted, now 8,912,909, issued on Dec. 16, 2014.
Application 14/076,556 is a continuation of application No. 13/412,428, filed on Mar. 5, 2012, granted, now 8,581,732, issued on Nov. 12, 2013.
Application 13/412,428 is a continuation of application No. 11/366,208, filed on Mar. 1, 2006, granted, now 8,130,105, issued on Mar. 6, 2012.
Claims priority of provisional application 60/657,759, filed on Mar. 1, 2005.
Claims priority of provisional application 60/657,596, filed on Mar. 1, 2005.
Claims priority of provisional application 60/657,281, filed on Mar. 1, 2005.
Claims priority of provisional application 60/657,268, filed on Mar. 1, 2005.
Prior Publication US 2021/0174955 A1, Jun. 10, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. G16H 40/67 (2018.01); A61B 5/00 (2006.01); A61B 5/0205 (2006.01); A61B 5/024 (2006.01); A61B 5/026 (2006.01); A61B 5/0295 (2006.01); A61B 5/145 (2006.01); A61B 5/1455 (2006.01); A61B 5/1495 (2006.01); G16H 10/40 (2018.01); A61B 1/00 (2006.01)
CPC G16H 40/67 (2018.01) [A61B 5/0022 (2013.01); A61B 5/0205 (2013.01); A61B 5/02416 (2013.01); A61B 5/0261 (2013.01); A61B 5/0295 (2013.01); A61B 5/14532 (2013.01); A61B 5/14546 (2013.01); A61B 5/1455 (2013.01); A61B 5/14551 (2013.01); A61B 5/14552 (2013.01); A61B 5/1495 (2013.01); A61B 5/6815 (2013.01); A61B 5/6826 (2013.01); A61B 5/6829 (2013.01); A61B 5/6832 (2013.01); A61B 5/6838 (2013.01); A61B 5/7221 (2013.01); A61B 5/7246 (2013.01); A61B 5/7275 (2013.01); A61B 5/7278 (2013.01); A61B 5/7405 (2013.01); A61B 5/742 (2013.01); A61B 5/746 (2013.01); A61B 5/7475 (2013.01); G16H 10/40 (2018.01); A61B 1/00 (2013.01); A61B 5/02427 (2013.01); A61B 2562/08 (2013.01); A61B 2562/085 (2013.01); A61B 2562/185 (2013.01); A61B 2562/222 (2013.01); Y10S 439/909 (2013.01)] 20 Claims
OG exemplary drawing
 
1. A patient monitoring system comprising:
a processor configured to:
receive physiological signals from one or more physiological sensors,
calculate measurements of a set of physiological parameters based at least in part on the one or more physiological signals, wherein the set of physiological parameters comprises an oxygen saturation parameter and at least two different hemoglobin parameters;
derive a value of an additional physiological parameter at least in part from the oxygen saturation parameter and the at least two different hemoglobin parameters;
cause a display of the patient monitoring system to display a default parameter indicator comprising at least some of the measurements of the set of physiological parameters;
receive an indication that a user has activated a button on the patient monitoring system; and
in response to receiving the indication, cause, for a predetermined period of time, the display of the patient monitoring system to replace the default parameter indicator with a second parameter indicator, wherein the second parameter indicator corresponds to an indicator of: the oxygen saturation parameter, at least one of the at least two different hemoglobin parameters, or the additional physiological parameter.